Pilot OVERNIGHT study: Assessing the efficacy of a nOVEl approach for impRoviNg symptoms in people with pre-chronic obstructive pulmonary disease usInG Hepa fiLTers
Not Applicable
- Conditions
- pre-chronic obstructive pulmonary diseaseRespiratory - Chronic obstructive pulmonary disease
- Registration Number
- ACTRN12624000284561
- Lead Sponsor
- The University of Melbourne
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Participants will be identified as having pre-COPD based on both respiratory symptoms and lower baseline lung function. Respiratory symptoms will be identified from the ECRHS IV short survey, including questions on current wheeze, current asthma, current asthma medication, current nasal allergy, chronic cough, chronic phlegm, and use of inhaled steroid medication. Lower baseline lung function will be identified as lower 50 percentile of pre-bronchodilator FEV1/FVC using GLI equation lung function reference at ECRHS IV.
Exclusion Criteria
Participants do not meet the spirometric criteria for COPD (post-bronchodilator FEV1/FVC <0.7) at ECRHS IV.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method